Nakahara Yujiro, Takachi Ko, Tsujimura Naoto, Wakasugi Masaki, Hirota Masaki, Matsumoto Takashi, Takemoto Hiroyoshi, Nishioka Kiyonori, Oshima Satoshi
Dept. of Surgery, Kinki Central Hospital.
Gan To Kagaku Ryoho. 2017 Nov;44(12):1161-1163.
Malignant stricture and fistula of the esophagus and tracheobronchus adversely affect the quality of life(QOL)in patients with advanced esophageal cancer. Stenting is one ofthe therapies available for these patients. We investigated the outcomes ofesophagus and tracheobronchial stenting in our institution. Eight patients with advanced esophageal cancer underwent double stenting from 2010 to 2016. Among them, 4 patients underwent double stenting as planned. One patient underwent an emergency tracheal stenting because ofstenosis ofthe trachea caused by esophageal stenting. Three patients underwent tracheobronchial stenting later on because ofan increase in the tumor size after esophageal stenting. Dysphagia score was improved in 5(67.5%)out ofthe 8 patients. Respiratory symptoms were improved in all patients, and 4 patients(50.0%) were discharged. The median survival time after esophageal stenting was 70.5 days. Esophagus and tracheobronchial stenting for advanced esophageal cancer was useful for the improvement of the QOL.
食管癌及气管支气管恶性狭窄与瘘对晚期食管癌患者的生活质量有不利影响。支架置入是针对这些患者的可用治疗方法之一。我们调查了本院食管及气管支气管支架置入的疗效。2010年至2016年,8例晚期食管癌患者接受了双支架置入。其中,4例患者按计划接受了双支架置入。1例患者因食管支架置入导致气管狭窄而接受了紧急气管支架置入。3例患者因食管支架置入后肿瘤增大,随后接受了气管支气管支架置入。8例患者中有5例(67.5%)吞咽困难评分得到改善。所有患者的呼吸道症状均得到改善,4例患者(50.0%)出院。食管支架置入后的中位生存时间为70.5天。晚期食管癌的食管及气管支气管支架置入有助于改善生活质量。